Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 10 of 10 results for cg61

  1. Irritable bowel syndrome in adults: diagnosis and management (CG61)

    This guideline covers diagnosing and managing irritable bowel syndrome (IBS) in people aged 18 and over. It details how to accurately diagnose IBS, and aims to improve the quality of life for adults with IBS by promoting effective management using dietary and lifestyle advice, pharmacological therapy and referral for psychological interventions.

  2. Irritable bowel syndrome in adults (QS114)

    This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.

  3. Improving evidence-based management of irritable bowel syndrome across Somerset

    Despite the publication of NICE Clinical Guideline 61 (CG61) in 2008 aiming for appropriate management of irritable bowel syndrome (IBS)

  4. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    Recommendation ID CG61/3 Question Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS? Any...

  5. Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related outcomes?

    Recommendation ID CG61/4 Question Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable

  6. Herbal medicines:- Are Chinese and non-Chinese herbal medicines safe and effective as first-line therapy in the treatment of [Irritable bowel syndrome] (IBS), and which is the most effective and safe option?

    Recommendation ID CG61/5 Question Herbal medicines:- Are Chinese and non-Chinese herbal medicines safe and effective as first-line...

  7. Coeliac disease (QS134)

    This quality standard covers recognising, assessing and managing coeliac disease in adults, young people and children. It describes high-quality care in priority areas for improvement.

  8. Irritable bowel syndrome with constipation in adults: linaclotide (ESNM16)

    This evidence summary has been updated and replaced by NICE guideline CG61.

  9. Research recommendations

    CG61/2 | Psychological interventions:- Are the psychological interventions [cognitive